CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
CDC’s Vaccines for Children Program Addendum : Special Considerations for Nirsevimab
-
10/18/2023
-
Series: Vaccines for Children
[PDF-156.47 KB]
Details:
-
Corporate Authors:
-
Description:Nirsevimab is an FDA-licensed monoclonal antibody that provides passive immunity against RSV-associated infection. On August 3, 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend nirsevimab as an immunization for all infants aged <8 months, as well as some children up to age 20 months (see ACIP recommendations), and a VFC resolution was passed to include nirsevimab in the VFC program. This addendum provides supplemental information and guidance related to the addition of the nirsevimab immunization to the VFC formulary.
NCIRDwt
operations-guide-nirsevimab-addendum.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Pages in Document:2 unnumbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
